3'-Ethoxy-[1,1'-biphenyl]-4-carbaldehyde

Catalog No.: 
ACCVJR892
CAS No.: 
1380573-85-2
Molecular Formula: 
C15H14O2
Molecular Weight: 
226.27
3'-Ethoxy-[1,1'-biphenyl]-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$175.00InquiryInquiry
1g98%$539.00InquiryInquiry
5g98%$2641.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3'-Ethoxy-[1,1'-biphenyl]-4-carbaldehyde
IUPAC Name3'-ethoxy-[1,1'-biphenyl]-4-carbaldehyde
MDL No.MFCD22690484
Molecular FormulaC15H14O2
Molecular Weight226.27
SMILESO=CC1=CC=C(C2=CC=CC(OCC)=C2)C=C1
InChI KeyZWYXKBMDFOXWAB-UHFFFAOYSA-N
Synonym3-ethoxybiphenyl-4-carbaldehyde;3-ETHOXY-[1,1-BIPHENYL]-4-CARBALDEHYDE;[1,1'-Biphenyl]-4-carboxaldehyde, 3'-ethoxy-
CAS No.1380573-85-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338-P405-P501

Synthetic Route by SureRoute

1. ACCVJR892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJONT796 route compound structure diagram
    ACJONT79690555-66-1In Stock
  2. Plus
  3. ACGPLR128 route compound structure diagram
    ACGPLR1281122-91-4In Stock
  4. Then
  5. ACCVJR892 route product structure diagram
    ACCVJR8921380573-85-2
Inquiry

2. ACCVJR892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRCME097 route compound structure diagram
    ACRCME0972655-84-7In Stock
  2. Plus
  3. ACYVBO782 route compound structure diagram
    ACYVBO78287199-17-5In Stock
  4. Then
  5. ACCVJR892 route product structure diagram
    ACCVJR8921380573-85-2
Inquiry

3. ACCVJR892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCVJR892 route product structure diagram
    ACCVJR8921380573-85-2
Inquiry

Comments (0)